In a virtual hearing in Newark, N.J., Purdue Pharma admitted it didn’t maintain an effective program to prevent illegal drug distribution and that it provided misleading information to the Drug Enforcement Administration.
The drugmaker also admitted to paying kickbacks to physicians to induce them to write more opioid prescriptions. The kickbacks were made in the form of a speakers program, according to the report.
The guilty plea comes one week after bankruptcy Judge Robert Drain approved Purdue Pharma’s $8.3 billion civil settlement with the U.S. Justice Department.
The Stamford, Conn.-based drugmaker filed for Chapter 11 bankruptcy protection last year, citing mounting legal liability.
More articles on opioids:
Congressmen urge Justice Department to revise Purdue Pharma settlement
Indivior to pay $289M in criminal penalties for Suboxone marketing
Medical students harbor stigma against patients with substance abuse disorders, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
